Leandro A Alves Avelar

4PUBLICATIONS
16CO-AUTHORS
Molecular targetsGene and molecular therapyChemical engineering design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 24, 2022
Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies.

Aaron Burmeister, Alexa Stephan, Leandro A Alves Avelar

|Dec 24, 2021
Designing HDAC-PROTACs: lessons learned so far.

Fabian Fischer, Leandro A Alves Avelar, Laoise Murray

|May 07, 2021
A short overview of resistance to approved histone deacetylase inhibitors.

Fabian Fischer, Leandro A Alves Avelar

|Aug 07, 2019
Structure-based design of selective histone deacetylase 6 zinc binding groups.

Leandro A Alves Avelar, Dusan Ruzic, Nemanja Djokovic

Pageof 1